IRESSA vs VONJO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. IRESSA and VONJO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IRESSA	VONJO
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	GEFITINIB	PACRITINIB CITRATE
Manufacturer	Astrazeneca	Sobi
Dosage forms	Tablet	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma	Primary Myelofibrosis

iressa vonjo

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

GEFITINIB

PACRITINIB CITRATE

Manufacturer

Astrazeneca

Sobi

Dosage forms

Tablet

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma

Primary Myelofibrosis

Frequently asked questions

What is the difference between Iressa and Vonjo?

Iressa contains Gefitinib, while Vonjo contains Pacritinib Citrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.